Motapizone
- Level
- Commodity
- Parent
- 51161500
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51161547This classification denotes a phosphodiesterase inhibitor with the molecular formula C12H12N4OS, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier C4A61P8A37, chemically known as 3(2h)-pyridazinone, 4,5-dihydro-6-(4-imidazol-1-yl-2-thienyl)-5-methyl- but generally known as motapizone, which bears US NIH Compound Identifier 65819. European Medicines Agency schedules Motapizone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09075MIG. The term MOTAPIZONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 39, No. 5, 1985, List 25). MOTAPIZONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule motapizone under HS 29349990 and SITC 51579. As of Q4 2014, MOTAPIZONE remains the US FDA Preferred Term for this commodity. Motapizone bears US NLM identifiers UMLS ID C0066826 and NCI Concept Code C66205. SMILES: CC1CC(=O)NN=C1C2=CC(=CS2)N3C=CN=C3.
Same parent
Under 51161500 · 56Activities that produce or sell this
KBLI · 9Inherited from family 51160000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.